Marksans Pharma Limited Overview
Get informed when a big investor buys or sells
+ Follow26.84
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, MARKSANS.NS shows a P/E ratio of 26.84. That is above the sector sector average of 24.62. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 24.62. Marksans Pharma Limited is at 26.84, which is higher that average. That is roughly 9.0% above the sector mean. Use the comparison chart on this page to see how MARKSANS.NS stacks up against individual peers as well.
Investors watch MARKSANS.NS's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Marksans Pharma Limited's latest reading is 26.84. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Marksans Pharma Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 26.84) with ownership activity and broader fundamentals.
